3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide,
4-pyridinylmethyl-3-(4-chlorophenyl) adamantane carboxamide,
ABC 294640,
ABC-294640,
ABC294640,
ABC294640,
915385-81-8,
Opaganib,
ABC-294640,
CHEMBL2158685,
ABC 294640,
UNII-DRG21OQ517,
DRG21OQ517,
Yeliva,
Opaganib (ABC294640),
GTPL6624,
SCHEMBL1548333,
CHEBI:124965,
HMS3402P05,
BCP08959,
EX-A1962,
3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,
BDBM50393642,
AKOS027327311,
API0017247,
CS-0877,
DB12764,
SB17167,
HY-16015,
S7174,
BRD-A70814879-003-01-8,
ABC294640|915385-81-8|ABC-294640,
(1s,3r,5R,7S)-3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,
D0X6BX,
CID15604015,
C548780,
4-pyridinylmethyl-3-(4-chlorophenyl) adamantane carboxamide,
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide,
Tricyclo(3.3.1.13,7)decane-1-carboxamide, 3-(4-chlorophenyl)-N-(4-pyridinylmethyl)-,